secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-09-15T17:44:55+00:00
Accession:  0001193125-26-391682
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health issues equity to retire debt and acquire Napo Therapeutics minority stake
--------------------------------------------------------------------------------

- Issued 557,377 shares to Lincoln Alternative to retire 6% convertible note with $175,016.36 balance on Sept 11, 2026.
- Exchanged 304,473 total shares to Streeterville for 9.2 Series Q preferred shares across 3 agreements (Jul 7, Sep 11, Sep 14, 2026).
- Closed Sep 15 purchase of a shareholder's Napo Therapeutics S.p.A. stake for 535,000 shares plus pre-funded warrant for 2,077,255 shares.
- All issuances under Section 3(a)(9) and 4(a)(2) exemptions; shares free of restrictive legends with Rule 144 holding-period tacking.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526391682/0001193125-26-391682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526391682/d162139d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-391682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer